A team in the United States has identified how bacteria switch on the genetic machinery that enables bugs to evolve resistance to antibiotics like penicillin. The discovery raises the possibility of developing pharmaceuticals that will be more effective against infections caused by staphylococci bacteria. Staphylococci are a family of bacteria that can infect wounds and cause food poisoning. The bacteria are a particular problem in hospitals because they rapidly become resistant to antibiotics. These superbugs, as they are commonly called, are responsible for hundreds of hospital deaths each year in the UK alone.
Scientists believe the bacteria become resistant to antibiotics by switching on two genes.
This process is controlled by a complex pathway of signals triggered when penicillin binds to the bacteria. A team at the University of California at San Francisco has now identified the chain of reactions that makes up this signalling pathway. The research, which is published in the journal Science, was carried out by Hong-Zhong Zhang and colleagues.